VTv Therapeutics slashes 65% of workforce, focuses on its diabetes drug By: MarketWatch December 06, 2021 at 18:43 PM EST VTv Therapeutics Inc. said it reduced its workforce by about 65% as it prioritizes development of diabetes drug TTP399. Read More >> Related Stocks: Vtv Theraptcs Cl A